EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Lactobacillus plantarum ATG‐K2 in Bacterial Vaginosis: In Vitro and In Vivo Evidence

Yeon-Hwa Park iD, Juyi Park iD, Ye-Won Kang, Jihee Kang iD

Microbiology and Immunology · 2025

DOI: 10.1111/1348-0421.70001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology and Immunology, 2025. Verfasst von Yeon-Hwa Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: AtoGen Co. Ltd, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Lactiplantibacillus plantarum, Vaginosis, Bacterial, Gardnerella vaginalis, Probiotics. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial vaginosis (BV) is characterized by reduced vaginal lactobacilli and pathogenic bacteria proliferation, leading to symptoms such as vaginal epithelial cell detachment and unpleasant odor, along with various complications. Most Lactobacillus species play a crucial role in not only inhibiting BV, but also maintaining vaginal health. We aimed to determine whether Lactobacillus plantarum ATG‐K2 has therapeutic and preventive effects against Gardnerella vaginalis (GV), a representative pathogen of BV. In vitro cell assays confirmed that ATG‐K2 clusters within cells without cytotoxic effects and inhibits both the cytotoxicity and GV adhesion. Furthermore, biofilm formation assays using crystal violet revealed that ATG‐K2 disrupts GV‐formed biofilms. In GV‐induced BV mouse models, ATG‐K2 reduced clue cell formation and sialidase activity, thereby addressing the key aspects of BV. Additionally, when ATG‐K2 was administered, the measurement of GV DNA within the vaginal tissue revealed a reduction in GV. In conclusion, ATG‐K2 holds promise as a therapeutic agent for BV by inhibiting GV colonization and the associated pathology, potentially offering an alternative to antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactiplantibacillus plantarumVaginosis, BacterialGardnerella vaginalisProbioticsFemaleAnimalsMiceHumansVaginaDisease Models, AnimalBiofilmsBacterial AdhesionEpithelial CellsNeuraminidase

Stichwörter der Autor:innen

Lactobacillus plantarumbacterial vaginosisbiofilmgardnerella vaginalislive biotherapeutic products

Substanzen

Neuraminidase

Autor:innen und Institutionen

  • AtoGen Co. Ltd, Daejeon, Republic of Korea.
  • Biowave W. 606, MCC B, Ewha Womans University Medical Center, Seoul, Republic of Korea.

ORCID-Profile: Yeon-Hwa Park, Juyi Park, Jihee Kang

Zitieren

APA

Park, Y. H., Park, J., Kang, Y. W., & Kang, J. (2025). Therapeutic Potential of Lactobacillus plantarum ATG‐K2 in Bacterial Vaginosis: In Vitro and In Vivo Evidence. Microbiology and Immunology. https://doi.org/10.1111/1348-0421.70001

Vancouver

Park YH, Park J, Kang YW, Kang J. Therapeutic Potential of Lactobacillus plantarum ATG‐K2 in Bacterial Vaginosis: In Vitro and In Vivo Evidence. Microbiology and Immunology. 2025. doi:10.1111/1348-0421.70001

BibTeX
@article{Park2025,
  author = {Park, Yeon-Hwa and Park, Juyi and Kang, Ye-Won and Kang, Jihee},
  title = {Therapeutic Potential of Lactobacillus plantarum ATG‐K2 in Bacterial Vaginosis: In Vitro and In Vivo Evidence},
  journal = {Microbiology and Immunology},
  year = {2025},
  doi = {10.1111/1348-0421.70001}
}
Kostenlos starten →